Acute pyelonephritis is a bacterial infection involving the renal parenchyma and renal pelvis and represents an important form of upper urinary tract infection. The clinical presentation commonly includes fever, chills, flank pain, dysuria, urinary frequency, nausea, and vomiting. Prompt recognition and appropriate antimicrobial treatment are essential to prevent complications such as renal abscess, sepsis, and renal injury.
We report a hypothetical case of a 32-year-old woman who presented with high-grade fever, chills, right-sided flank pain, dysuria, and increased urinary frequency. Clinical examination revealed right costovertebral angle tenderness. Laboratory investigations demonstrated leukocytosis, elevated inflammatory markers, and urinalysis findings consistent with urinary tract infection. Urine culture isolated Escherichia coli. Renal ultrasonography demonstrated inflammatory changes involving the right kidney without evidence of urinary obstruction. The patient was diagnosed with acute uncomplicated pyelonephritis and treated with appropriate antibiotic therapy and supportive care.
This case highlights the importance of recognizing the characteristic clinical features of acute pyelonephritis and emphasizes the role of urinalysis, urine culture, laboratory investigations, and appropriate imaging in selected patients. Early diagnosis and timely antimicrobial therapy are essential for preventing progression to severe infection and other complications.
Acute pyelonephritis is an infection involving the upper urinary tract, particularly the renal pelvis and renal parenchyma. It is commonly caused by ascending bacterial infection from the lower urinary tract, with Escherichia coli being the predominant causative organism.

The condition may present with systemic and urinary symptoms, including fever, chills, flank pain, dysuria, urinary frequency, nausea, and vomiting. The combination of characteristic clinical findings and laboratory evidence of urinary infection is central to diagnosis. Urine culture with antimicrobial susceptibility testing is recommended to identify the causative organism and guide antimicrobial treatment.
Imaging is not routinely required in uncomplicated cases but may be useful when there is concern for urinary obstruction, anatomic abnormalities, treatment failure, or complications.
Management primarily involves appropriate antimicrobial therapy, with treatment selection influenced by the clinical severity, patient characteristics, and local antimicrobial susceptibility patterns. Supportive treatment is also important for controlling fever, pain, and maintaining adequate hydration.
We report a hypothetical case of acute pyelonephritis presenting with fever, flank pain, and urinary symptoms, followed by clinical, laboratory, microbiological, and imaging evaluation confirming the diagnosis.
A 32-year-old woman presented with a 3-day history of high-grade fever associated with chills and right-sided flank pain. She also reported burning micturition, increased urinary frequency, and generalized weakness. The flank pain had progressively increased over the preceding 24 hours and was associated with reduced appetite.
There was no significant history of previous renal disease, recurrent urinary tract infections, urinary tract instrumentation, or known urinary tract abnormalities. She had no history of previous malignancy or major chronic illness.
On general examination, the patient was conscious and oriented but appeared acutely ill and mildly dehydrated. Her temperature was elevated, while other vital parameters were stable. Abdominal examination revealed mild tenderness over the right flank. Marked tenderness was elicited over the right costovertebral angle.
Laboratory investigations revealed leukocytosis with neutrophilic predominance and elevated inflammatory markers. Renal function parameters were within acceptable limits.
Urinalysis demonstrated significant pyuria and bacteriuria, with positive leukocyte esterase and nitrite testing, supporting the diagnosis of urinary tract infection.

Urine culture grew Escherichia coli, and antimicrobial susceptibility testing was performed to guide antibiotic selection.

Urine culture and susceptibility testing are important components of the evaluation of acute pyelonephritis.

Renal ultrasonography demonstrated inflammatory changes involving the right kidney without evidence of hydronephrosis or an obstructing calculus. There was no imaging evidence of a renal abscess.

Based on the clinical presentation, laboratory findings, positive urine culture, and imaging assessment, the patient was diagnosed with acute right-sided pyelonephritis.
The diagnosis was established based on:
The overall findings were consistent with acute uncomplicated pyelonephritis.
After clinical assessment and review of the microbiological findings, antimicrobial therapy was initiated and subsequently tailored according to the urine culture and susceptibility results. Supportive treatment included adequate hydration, antipyretic therapy, and symptomatic management of flank pain.
The patient demonstrated progressive clinical improvement following initiation of treatment. Fever and chills subsided, urinary symptoms decreased, and the flank pain gradually resolved. Renal function remained stable during treatment.
The patient completed the prescribed antimicrobial course with regular clinical monitoring. No evidence of renal abscess, urinary obstruction, sepsis, or other acute complications was identified during the treatment period.
One Week
Four Weeks
Three Months
Acute pyelonephritis is a potentially serious upper urinary tract infection that can progress to systemic infection if not recognized and treated promptly. The clinical presentation is typically characterized by fever, flank pain, urinary symptoms, and laboratory evidence of urinary infection.
Escherichia coli is the most common causative organism. Identification of the responsible pathogen through urine culture allows antimicrobial treatment to be appropriately directed, particularly in the setting of increasing antimicrobial resistance.
Physical examination remains important in patients with suspected pyelonephritis. Costovertebral angle tenderness, when associated with fever and urinary symptoms, supports involvement of the upper urinary tract rather than an isolated lower urinary tract infection.
Urinalysis provides important evidence of urinary infection, while urine culture and antimicrobial susceptibility testing help identify the causative organism and guide treatment.
Imaging has a selective role in acute pyelonephritis. Uncomplicated cases can generally be diagnosed clinically and treated without routine imaging. However, imaging becomes particularly relevant in patients with risk factors for complications, atypical presentations, persistent symptoms, treatment failure, suspected obstruction, or possible renal abscess.
Ultrasonography can assist in identifying urinary obstruction and other structural abnormalities, while computed tomography can provide more detailed assessment of renal involvement and complications when clinically indicated.
Treatment requires appropriate antimicrobial therapy together with supportive management. In uncomplicated cases, patients who are clinically stable and able to tolerate oral treatment may be managed without hospitalization, whereas patients with severe disease or inability to tolerate oral therapy may require intravenous treatment and closer monitoring.
This hypothetical case demonstrates the importance of recognizing the combination of fever, flank pain, urinary symptoms, and laboratory evidence of infection. Prompt microbiological evaluation and appropriate treatment can lead to rapid clinical improvement and help prevent serious complications.
The prognosis of acute pyelonephritis is generally favorable when the condition is recognized early and treated appropriately. However, delayed treatment, urinary obstruction, diabetes, immunosuppression, resistant organisms, and other high-risk conditions may increase the likelihood of complications.
Potential complications include sepsis, renal abscess, obstruction-related infection, and renal injury. Continued clinical assessment is therefore important, particularly in patients who fail to respond to initial therapy or develop persistent systemic symptoms.
Acute pyelonephritis should be considered in patients presenting with fever, flank pain, and symptoms of urinary tract infection, particularly when accompanied by costovertebral angle tenderness and abnormal urinalysis findings.
This hypothetical case highlights the importance of clinical assessment, urinalysis, urine culture, antimicrobial susceptibility testing, and selective use of imaging in establishing the diagnosis and guiding treatment. Early recognition and appropriate antimicrobial therapy remain essential for achieving clinical recovery and preventing complications.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
2.
Proton Therapy Fails to Beat IMRT in Prostate Cancer
3.
Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights
4.
Detecting pancreatic cancer through changes in body composition and metabolism
5.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
The Benefits and Risks of Cervical Conization
3.
Unveiling the Hidden Causes of Anemia: A Comprehensive Look at a Common Condition
4.
Critical Care Updates on Hematopoietic Dysfunction During Prolonged Critical Illness
5.
Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing Fatigue During Cancer Treatment
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation